☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Esbriet
Insights+: Breakthrough Therapy Designation by the US FDA in 2020
March 11, 2021
Roche Reports the US FDA's Acceptance of sNDA and Granted Priority Review for Esbriet (pirfenidone) to Treat UILD
January 21, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
